How do I taper Suboxone (buprenorphine/naloxone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 1, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Suboxone (Buprenorphine/Naloxone) Tapering Protocol

A slow, individualized tapering approach of 10% per month or slower is the most effective method for tapering Suboxone to minimize withdrawal symptoms and reduce risk of relapse. 1, 2

Pre-Tapering Assessment and Planning

  • Verify current dose and duration of Suboxone treatment
  • Screen for concurrent benzodiazepine use (dangerous combination)
  • Assess for opioid use disorder (OUD) using DSM-5 criteria
  • Evaluate for anxiety, depression, and other mental health conditions that may worsen during tapering
  • Discuss tapering goals, timeline, and potential withdrawal symptoms with patient
  • Create a written taper agreement outlining the collaborative process

Tapering Schedule Options

Standard Taper (Recommended for Most Patients)

  • Reduce dose by 10% of the previous dose per month
  • Example for 16mg/day starting dose:
    • Month 1: 14.4mg/day
    • Month 2: 13.0mg/day
    • Month 3: 11.7mg/day
    • Continue this pattern until reaching the smallest available dose

Slower Taper (For Long-Term Users or Anxious Patients)

  • Reduce dose by 5% of the previous dose per month
  • More gradual approach for patients on long-term therapy (≥1 year)
  • Particularly useful for patients with high anxiety about tapering

Micro-Taper (For Final Stages)

  • When reaching the smallest available dose (2mg film):
    • Use ruler/razor method to cut films into halves (acceptable for content uniformity) 3
    • Avoid cutting into quarters (poor content uniformity) 3
    • Extend interval between doses (every other day, then every third day)

Managing Withdrawal Symptoms

Common Withdrawal Symptoms

  • Anxiety, irritability, insomnia, dysphoria
  • Muscle aches, abdominal cramps, nausea, diarrhea
  • Diaphoresis, mydriasis, tremor, tachycardia

Adjunctive Medications

  • α2-Adrenergic Agonists: Clonidine (0.1-0.2mg every 6 hours) for sympathetic hyperactivity 1, 2
  • Loperamide: For gastrointestinal symptoms
  • Sleep aids: Trazodone or mirtazapine for insomnia
  • Pain management: Scheduled acetaminophen (not exceeding 3000mg daily)
  • Anti-anxiety: Hydroxyzine or gabapentin (non-benzodiazepine options)

Monitoring and Follow-Up

  • Schedule monthly visits during the tapering process
  • Monitor for:
    • Withdrawal symptoms
    • Changes in mood or suicidal thoughts
    • Cravings or return to substance use
    • Pain control
  • Adjust taper rate based on patient response:
    • If withdrawal symptoms are severe, pause taper or return to previous dose
    • If patient is tolerating well, continue with planned schedule

Special Considerations

  • Pause points: Plan for pauses in the taper at 8mg, 4mg, 2mg, and 1mg to allow neuroadaptation
  • Psychological support: Incorporate cognitive behavioral therapy, mindfulness, and stress management techniques
  • Exercise: Regular physical activity can help manage withdrawal symptoms
  • Avoid rapid tapers: Tapering too quickly increases risk of withdrawal, relapse, and treatment failure 1
  • Never abruptly discontinue: This can lead to severe withdrawal and increased risk of returning to illicit opioid use 1, 2

When to Slow or Pause the Taper

  • Significant withdrawal symptoms that interfere with daily functioning
  • Major life stressors or changes (job loss, relationship changes, housing issues)
  • Development or worsening of mental health symptoms
  • Patient request due to feeling overwhelmed

Common Pitfalls to Avoid

  • Tapering too rapidly: Can lead to withdrawal, treatment failure, and seeking alternative opioid sources 1, 2
  • Inadequate symptom management: Failure to address withdrawal symptoms increases taper failure risk
  • Insufficient follow-up: Regular monitoring is essential to adjust the taper as needed
  • Rigid adherence to a schedule: Flexibility based on patient response is crucial for success
  • Cutting films into quarters: Research shows poor content uniformity when cutting Suboxone films into quarters 3

By following this structured, patient-centered approach to Suboxone tapering, you can minimize withdrawal symptoms and optimize the chances of successful discontinuation while prioritizing patient safety and comfort.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Opioid Management and Tapering

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.